Key Takeaways
- The recent presidential election elicited some jokes and some anxiety about the coming Trump Administration and its impact on the biopharma industry.
- Galien Forum speakers discussed the potential implications for the IRA and NIH funding.
- One panelist stressed the importance of emphasizing that the NIH is vital to the life sciences industry and biomedical innovation.
The prospects of a second Trump Administration dominated discussions by the most powerful and influential people in life sciences at the recent Galien Forum, revealing some trepidation about the changes...
Zeke Emanuel, co-director of the University of Pennsylvania Healthcare Transformation Institute, jokingly asked during one panel at the 7 November conference how the new administration could affect fluoridation of water....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?